| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 03/28/2002 | WO2002024651A1 A process for producing 2-amino-4,6-disubstituted nicotinic acid ester analogs |
| 03/28/2002 | WO2002024647A1 Ep4 receptor agonists containing 8-azaprostaglandin derivatives as the active ingredient |
| 03/28/2002 | WO2002024639A1 Cyclopentane derivatives as therapeutic agents |
| 03/28/2002 | WO2002024636A2 N-acylsulfonamide apoptosis promoters |
| 03/28/2002 | WO2002024233A2 Control of nk cell function and survival by modulation of ship activity |
| 03/28/2002 | WO2002024225A1 Use of immidazoquinolinamines as adjuvants in dna vaccination |
| 03/28/2002 | WO2002024224A2 Use of replication-deficient poxvirus vector to boost cd4+ t cell immune response to antigen |
| 03/28/2002 | WO2002024220A2 Vaccine comprising heat stress proteins from herbaceous plants |
| 03/28/2002 | WO2002024219A1 Growth factor complex |
| 03/28/2002 | WO2002024217A1 Use of il-8 protein modulators in the treatment of viral infections |
| 03/28/2002 | WO2002024214A2 Use of glp -2 in combination with another therapeutic agent in bone-related and nutrition-related disorders |
| 03/28/2002 | WO2002024194A2 Use of statins (hmg-coa reductase inhibitors) for the preparation of medicament as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent |
| 03/28/2002 | WO2002024162A1 Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment |
| 03/28/2002 | WO2002004624A9 Novel g protein-coupled receptor protein and dna thereof |
| 03/28/2002 | WO2001090153A8 Reagents for cell selection and methods of use |
| 03/28/2002 | WO2001090106A3 Tryasolyl tropane derivatives as ccr5 modulators |
| 03/28/2002 | WO2001089493A3 Compositions containing a benzamide disulfide derivative for treating allergic diseases |
| 03/28/2002 | WO2001085762B1 Cancer diagnosis and assays for screening anti-cancer agents |
| 03/28/2002 | WO2001085202A3 Electroporation for introduction of molecules into cells |
| 03/28/2002 | WO2001083692A3 Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids |
| 03/28/2002 | WO2001083434A3 P-(sulfonyl)-aryl and heteroaryls amines |
| 03/28/2002 | WO2001080880A3 Apoptotic agents |
| 03/28/2002 | WO2001078774A3 Recombinant intracellular pathogen vaccines and methods for use |
| 03/28/2002 | WO2001078653A3 Graft rejection inhibition with ccr2 inhibitors |
| 03/28/2002 | WO2001077299A3 A METHOD TO PREVENT GRAFT REJECTION USING TGF-β TO INDUCE T SUPPRESSOR CELLS |
| 03/28/2002 | WO2001068839A3 Regulation of human lipoxin a4 receptor-like protein |
| 03/28/2002 | WO2001066596A3 Human fgf-23 gene and gene expression products |
| 03/28/2002 | WO2001066124A3 Composition for the treatment of heart failure |
| 03/28/2002 | WO2001066107A3 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases |
| 03/28/2002 | WO2001062793A3 Estrogen receptor beta variants and methods of detection thereof |
| 03/28/2002 | WO2001060389A3 Mistletoe extracts |
| 03/28/2002 | WO2001055357A3 Myeloid colony stimulating factor and uses thereof |
| 03/28/2002 | WO2001055356A3 Human protein kinases and protein kinase-like enzymes |
| 03/28/2002 | WO2001055341A3 Immunomodulatory polynucleotides in treatment of an infection by an intracellular pathogen |
| 03/28/2002 | WO2001051044A3 Substances for use in treating psoriasis |
| 03/28/2002 | WO2001038486A3 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 03/28/2002 | WO2001032216A3 Product comprising at least a no synthase inhibiting substance associated with at least a phospholipase a2 inhibiting substance |
| 03/28/2002 | WO2001022955A2 Novel combination of loteprednol and antihistamines |
| 03/28/2002 | WO2001009183A3 Polymorphisms in the human mdr-1 gene and applications thereof |
| 03/28/2002 | WO2001007405A3 New vitamin d derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments |
| 03/28/2002 | WO2000063241A9 Methods and compositions for modulating an immune response |
| 03/28/2002 | WO2000047231A9 Novel antisense inhibition of rad51 |
| 03/28/2002 | US20020038469 Delayed progression to aids by a missense allele of the ccr2 gene |
| 03/28/2002 | US20020038112 Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells |
| 03/28/2002 | US20020038002 To suppress immune system for therapy of symptoms associated with immune disorders such as allergies, transplanted tissue rejection and autoimmune diabetes, rheumatoid arthritis and multiple sclerosis |
| 03/28/2002 | US20020037927 Halogenated 2-amino-4, 5 heptenoic acid derivatives useful as nitric oxide synthase inhibitors |
| 03/28/2002 | US20020037919 Compositions and methods of paclitaxel for preventing psoriasis |
| 03/28/2002 | US20020037915 4-(4-(1- phenyl-5-propylpyrazol4-yl)(1,3-thiazol-2-yl))-5-methylthiothiophene-2 -carboxamidine, for example; complement inhibitors; treating tissue damage, inflammation, or autoimmune diseases |
| 03/28/2002 | US20020037909 Enamine derivatives |
| 03/28/2002 | US20020037900 Hydroxamic acid derivatives |
| 03/28/2002 | US20020037895 Wherein the lactone ring is modified; preventing or treating disorders or diseases mediated by LFA-1 (Leukocyte Function-associated Antigen-1) ICAM-1 (intercellular adhesion molecules) interactions; autoimmune disorders, inflammation |
| 03/28/2002 | US20020037892 Bis-arylsulfones |
| 03/28/2002 | US20020037878 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 03/28/2002 | US20020037852 Anticarcinogenic agents |
| 03/28/2002 | US20020037850 Genetic engineering; binding to antibodies |
| 03/28/2002 | US20020037836 Use of GLP for the treatment, prevention, diagnosis, and prognosis of bone-related and nutrition-related disorders |
| 03/28/2002 | US20020037835 Antitumor agents |
| 03/28/2002 | US20020037583 Transforming cells with preferfential nucleotide sequences; obtain cells, transform, with vector, express vector, recover preferential proteins |
| 03/28/2002 | US20020037549 ABC transport polynucleotides, polypeptides, and antibodies |
| 03/28/2002 | US20020037544 Detecting modulators of phosphorylation; obtain sample, incubate with modulator, screen sample for adjustment in phosphorylation activity |
| 03/28/2002 | US20020037543 Purging of cells using viruses |
| 03/28/2002 | US20020037524 Nucleotide sequences for use in diagnosis, treatment and prevention of cancer, inflammation, autoimmune disease and infections |
| 03/28/2002 | US20020037523 Nucleotide sequences coding polypeptide for use in the diagnosis, treatment and prevention of nervous system, autoimmune, inflammation, glomerulonephritis and osteoporosis disorders |
| 03/28/2002 | US20020037297 For therapy and prophylaxis allergic rhinitis, vasomotoric rhinitis, conjunctivitis, cold, and flu |
| 03/28/2002 | US20020037295 Oral or intranasal vaccines using hydrophobic complexes having proteosomes and lipopolysaccharides |
| 03/28/2002 | US20020037291 Sphingoglycolipid |
| 03/28/2002 | US20020037287 For diagnosis and therapy of myeloma and ovarian cancer |
| 03/28/2002 | US20020037285 For diseases such as rheumatoid arthritis, atherosclerosis, granulomatous diseases and multiple sclerosis |
| 03/28/2002 | US20020037282 Universal immunomodulatory cytokine-expressing bystander cell line and related compositions and methods of manufacture and use |
| 03/28/2002 | CA2433157A1 Cyclopentane derivatives as therapeutic agents |
| 03/28/2002 | CA2424394A1 Growth factor complex comprising an insulin-like growth factor binding protein bound to vitronectin |
| 03/28/2002 | CA2423284A1 Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines |
| 03/28/2002 | CA2423181A1 Isolated nucleic acid molecules which encode a soluble il-tif/il-22 receptor or binding protein which binds to il-tif/il-22, and uses thereof |
| 03/28/2002 | CA2423071A1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 03/28/2002 | CA2422923A1 Pyridine derivatives with ikb-kinase (ikk-.beta.) inhibiting activity |
| 03/28/2002 | CA2422868A1 Control of nk cell function and survival by modulation of ship activity |
| 03/28/2002 | CA2422863A1 Use of immidazoquinolinamines as adjuvants in dna vaccination |
| 03/28/2002 | CA2422820A1 Use of statins (hmg-coa reductase inhibitors) for the preparation of medicament as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent |
| 03/28/2002 | CA2422686A1 Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment |
| 03/28/2002 | CA2422215A1 B7-like molecules and uses thereof |
| 03/28/2002 | CA2421823A1 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 03/28/2002 | CA2421485A1 Water soluble rapamycin esters |
| 03/28/2002 | CA2420862A1 Protein phosphatases |
| 03/28/2002 | CA2420160A1 Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions |
| 03/27/2002 | EP1191100A2 Recombinant allergens from the Indianmeal Moth Plodia interpunctella |
| 03/27/2002 | EP1191036A2 Methods and compositions for diagnosing and treating disorders involving angiogenesis |
| 03/27/2002 | EP1191035A2 Three members of the cytokin-receptor class II family |
| 03/27/2002 | EP1191024A1 Thiadiazines and their use as inhibitors of metalloproteinases |
| 03/27/2002 | EP1190716A1 The leaves of cajanus cajan(l.) millsp and extract, formulation and uses thereof |
| 03/27/2002 | EP1190714A2 Method for the treatment of thromboembolic disorders in patients with aspirin resistance |
| 03/27/2002 | EP1190086A2 Genetic modification of male germ cells for generation of transgenic species and genetic therapies |
| 03/27/2002 | EP1190074A1 Recombinant anti-cd40 antibody and uses thereof |
| 03/27/2002 | EP1190072A2 22012, a novel human carboxypeptidase |
| 03/27/2002 | EP1190059A1 Sgip peptides |
| 03/27/2002 | EP1190051A2 Human transport proteins |
| 03/27/2002 | EP1190050A2 Human transcriptional regulator proteins |
| 03/27/2002 | EP1190049A1 Spliceosome protein and its use |
| 03/27/2002 | EP1190038A2 Bacterial protection against stress |
| 03/27/2002 | EP1190024A1 Grapeseed, cold-pressed grape oil, crushed grape and grape flour |
| 03/27/2002 | EP1189947A1 Anti-idiotypic antibodies of fibroblast growth factors and their use as medicines |